# Glabridin Inhibits Melanogenesis and Melanin Transfer via Wnt/β-Catenin Pathway and Rho Family GTPase-Mediated Dendritic Formation Suppression

**Authors:** Lili Li, Xiaoya Zhang, Guangyuan Tang, Jianxin Wu, Qing Huang

PMC · DOI: 10.3390/ph19030469 · Pharmaceuticals · 2026-03-12

## TL;DR

Glabridin, a natural compound, lightens skin by reducing melanin production and transfer through specific molecular pathways.

## Contribution

This study is the first to show glabridin's dual mechanism involving Wnt/β-catenin and Rho GTPase pathways.

## Key findings

- Glabridin inhibits melanin synthesis by downregulating β-catenin and MITF.
- Glabridin suppresses dendrite formation and melanin transfer by regulating Rho GTPases.
- Glabridin's effects are comparable to niacinamide in inhibiting melanin transfer.

## Abstract

Background: Glabridin, a natural compound derived from Glycyrrhiza glabra L., possesses skin-lightening effects. This study aims to further elucidate the depigmentation mechanism of glabridin by investigating its effects on melanogenesis and melanin transfer. Methods: We initially confirmed the anti-melanogenic effects of glabridin in MNT-1 human melanoma cells. Then, we investigated the mechanism of its anti-melanogenic effect by evaluating the protein expression of β-catenin and MITF via Western blot. To investigate melanin transfer, we compared glabridin’s efficacy with that of niacinamide, a recognized inhibitor of melanosome transfer and employed two complementary experimental models: (1) α-melanocyte-stimulating hormone (α-MSH)-stimulated MNT-1 cells to analyze dendrite formation, and (2) a UVB-irradiated co-culture system of MNT-1 cells and HaCaT keratinocytes to evaluate melanin transfer. Results: By measuring glabridin’s effects on melanin content, tyrosinase activity, and melanogenesis-related protein expression confirmed its inhibition of melanin synthesis. Further investigation demonstrated that glabridin suppresses melanogenesis by downregulating β-catenin and MITF, indicating inhibition of the Wnt/β-catenin pathway. Furthermore, in α-MSH-treated MNT-1 cells, both glabridin and niacinamide were found to suppress dendrite formation and elongation. In a UVB-exposed co-culture system, both glabridin and niacinamide inhibited melanin transfer to keratinocytes. Mechanistically, these effects were linked to the regulation of Rho GTPases (Rac1, RhoA, Cdc42) and suppression of F-actin reorganization. Conclusions: This study provides, for the first time, evidence that the skin-lightening effect of glabridin involves two complementary mechanisms: inhibition of melanogenesis through suppression of the Wnt/β-catenin pathway, and attenuation of both dendricity and melanin transfer via the influence of Rho family GTPases expression.

## Linked entities

- **Genes:** MITF (melanocyte inducing transcription factor) [NCBI Gene 4286], RAC1 (Rac family small GTPase 1) [NCBI Gene 5879], RHOA (ras homolog family member A) [NCBI Gene 387], CDC42 (cell division cycle 42) [NCBI Gene 998]
- **Proteins:** ctnnb1.S (catenin beta 1 S homeolog), LOC103429692 (polyphenol oxidase, chloroplastic-like), Act5C (Actin 5C)
- **Chemicals:** Glabridin (PubChem CID 124052), niacinamide (PubChem CID 936), UVB (PubChem CID 154464873)

## Full-text entities

- **Genes:** CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, RHOA (ras homolog family member A) [NCBI Gene 387] {aka ARH12, ARHA, EDFAOB, RHO12, RHOH12}, MITF (melanocyte inducing transcription factor) [NCBI Gene 4286] {aka CMM8, COMMAD, MI, MITF-A, WS2, WS2A}, CDC42 (cell division cycle 42) [NCBI Gene 998] {aka CDC42Hs, G25K, TKS}, RAC1 (Rac family small GTPase 1) [NCBI Gene 5879] {aka MIG5, MRD48, Rac-1, TC-25, p21-Rac1}, TYR (tyrosinase) [NCBI Gene 7299] {aka ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3}
- **Diseases:** melanoma (MESH:D008545)
- **Chemicals:** melanin (MESH:D008543), niacinamide (MESH:D009536), Glabridin (MESH:C107601)
- **Species:** Glycyrrhiza glabra (species) [taxon 49827], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13028802/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13028802/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC13028802/full.md

---
Source: https://tomesphere.com/paper/PMC13028802